Filters
clear all
Filters
Topics
Industry
Type
Mitchell Article

Data Analytics in Insurance Claims Processing: Trends & Benefits

Using data analytics in insurance claims processing can create a variety of benefits if done right, including identifying trends before they become problems and helping claims organizations develop data-driven business strategies.

Mitchell Virtual Event

Michigan No-Fault Fee Schedule: The Latest Updates [On-Demand Webinar]

On-Demand

On July 2, 2021, the new Michigan fee schedule will go into effect for services rendered on or after that date. Watch this webinar on-demand to hear about the latest updates from Mitchell regulatory, product and industry experts.

Mitchell Virtual Event

Michigan No-Fault Fee Schedule: What You Need to Know Before July 2

On-Demand

In this webinar on June 23 at 9:30 AM PT, Mitchell regulatory, product and industry experts will provide an update on the latest information, including what is still outstanding, and share key strategies for how our products and insurers may want to address the ambiguity and prepare for the effective date.

Workers' Comp Article

WorkCompWire: 5 Things You Should Know about IMEs and COVID-19

1 MIN READ

Though the COVID-19 pandemic has presented many challenges, workers’ compensation (WC) programs have continued to push claims forward – often with the assistance of independent medical examinations

Mitchell Article

As Crises Linger, U.S. Hospitals Continue to Face Headwinds

U.S. Hospitals have felt major impacts from the COVID-19 pandemic from financial and supply-chain challenges to staffing shortages due to increased exposure.

Mitchell Article

COVID—A Year Later

The COVID-19 pandemic has affected many facets of our lives from how we work & live to how we innovate & evolve without truly knowing what lies ahead.

Auto Casualty Article

Drug of the Month: Insights Into COVID-19 Vaccines and Workers' Comp

6 MIN READ

COVID-19 vaccination efforts continue to progress, after the Emergency Use Authorization (EUA) of two COVID-19 vaccines by the Food and Drug Administration (FDA) in late 2020. In late February 2021, a third vaccine was given approval to begin distribution.